FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

373691002: Oral hypoglycemic (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1198991015 Oral hypoglycemic (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1207468013 Oral hypoglycaemic en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1208280018 Oral hypoglycemic en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4496201000005119 Oralt blodsukkersænkende middel da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Oralt blodsukkersænkende middel Is a blodsukkersænkende middel false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Sulfonylurea (substance) Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    Product containing metformin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Product containing biguanide (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Product containing troglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Product containing thiazolidinedione (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Oral hypoglycaemic identification Component False Oralt blodsukkersænkende middel Inferred relationship Some
    Poisoning by metformin Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    forgiftning med oralt hypoglykæmikum Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Accidental poisoning by metformin Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Intentional poisoning caused by metformin (disorder) Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    forgiftning med metformin, uvist med hvilken hensigt Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Accidental phenformin poisoning Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Intentional phenformin poisoning Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    forgiftning med phenformin, uvist med hvilken hensigt Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    allergi over for hypoglykæmikum til oral anvendelse Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Allergy to biguanide (finding) Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Allergy to metformin (finding) Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Allergy to acarbose Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Oral hypoglycemic overdose Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Biguanide overdose Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Overdose of metformin Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Accidental overdose by metformin Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Intentional overdose by metformin Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    overdosis af metformin, uvist med hvilken hensigt Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    metforminhydrochloridprodukt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Metformin hydrochloride 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Metformin hydrochloride 850 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Troglitazone 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Troglitazone 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Troglitazone 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Product containing rosiglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Product containing precisely rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Product containing pioglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    blodsukkersænkende middel til oral anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    forgiftning med oralt biguanidderivat Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Rosiglitazone maleate 2mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Metformin hydrochloride 1 g oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    metforminhydrochlorid 500 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    rosiglitazonmaleat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Guar gum (substance) Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    Poisoning by phenformin Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Biguanide (substance) Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    blodsukkersænkende kombinationspræparat til oral anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    pioglitazonhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Alfa-glucosid-hæmmer Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    Biguanide oral hypoglycemic agent (substance) Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    Product containing biguanide (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    bivirkning af blodsukkersænkende præparat til oral anvendelse Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Biguanide overdose Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    forgiftning med oralt biguanidderivat Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    Adverse reaction to insulins and antidiabetic agents NOS Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    rosiglitazon 2 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oralt blodsukkersænkende middel Inferred relationship Some
    Sitagliptin (substance) Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    Miglitol (substance) Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    Acarbose (substance) Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    Vildagliptin (substance) Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    forgiftning med oralt sulfonylureaderivat Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some
    allergi over for hypoglykæmikum til oral anvendelse Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some 1
    Linagliptin (substance) Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    Alogliptin Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    Saxagliptin (substance) Is a False Oralt blodsukkersænkende middel Inferred relationship Some
    Allergy to guar gum (finding) Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some 2
    Guar gum adverse reaction Causative agent False Oralt blodsukkersænkende middel Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start